125 related articles for article (PubMed ID: 12197239)
1. Local treatment of brain tumors with targeted chimera cytotoxic proteins.
Debinski W
Cancer Invest; 2002; 20(5-6):801-9. PubMed ID: 12197239
[TBL] [Abstract][Full Text] [Related]
2. Clinical studies with targeted toxins in malignant glioma.
Rainov NG; Söling A
Rev Recent Clin Trials; 2006 May; 1(2):119-31. PubMed ID: 18473963
[TBL] [Abstract][Full Text] [Related]
3. Diphtheria toxin-based targeted toxin therapy for brain tumors.
Li YM; Vallera DA; Hall WA
J Neurooncol; 2013 Sep; 114(2):155-64. PubMed ID: 23695514
[TBL] [Abstract][Full Text] [Related]
4. Targeted toxin therapy for malignant astrocytoma.
Hall WA
Neurosurgery; 2000 Mar; 46(3):544-51; discussion 552. PubMed ID: 10719849
[TBL] [Abstract][Full Text] [Related]
5. Immunotoxin treatment of brain tumors.
Hall WA
Methods Mol Biol; 2001; 166():139-54. PubMed ID: 11217364
[No Abstract] [Full Text] [Related]
6. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.
Zovickian J; Johnson VG; Youle RJ
J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors.
Martell LA; Agrawal A; Ross DA; Muraszko KM
Cancer Res; 1993 Mar; 53(6):1348-53. PubMed ID: 8443815
[TBL] [Abstract][Full Text] [Related]
8. Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids.
Wenning LA; Murphy RM
Biotechnol Bioeng; 1999 Mar; 62(5):562-75. PubMed ID: 10099565
[TBL] [Abstract][Full Text] [Related]
9. Humanized immunotoxins: a new generation of immunotoxins for targeted cancer therapy.
Mathew M; Verma RS
Cancer Sci; 2009 Aug; 100(8):1359-65. PubMed ID: 19459847
[TBL] [Abstract][Full Text] [Related]
10. Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas.
Weaver M; Laske DW
J Neurooncol; 2003 Oct; 65(1):3-13. PubMed ID: 14649881
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice.
Laske DW; Ilercil O; Akbasak A; Youle RJ; Oldfield EH
J Neurosurg; 1994 Mar; 80(3):520-6. PubMed ID: 8113865
[TBL] [Abstract][Full Text] [Related]
12. Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia.
Johnson VG; Wrobel C; Wilson D; Zovickian J; Greenfield L; Oldfield EH; Youle R
J Neurosurg; 1989 Feb; 70(2):240-8. PubMed ID: 2783608
[TBL] [Abstract][Full Text] [Related]
13. Toxin-based targeted therapy for malignant brain tumors.
Chandramohan V; Sampson JH; Pastan I; Bigner DD
Clin Dev Immunol; 2012; 2012():480429. PubMed ID: 22400035
[TBL] [Abstract][Full Text] [Related]
14. Vascular protection by chloroquine during brain tumor therapy with Tf-CRM107.
Hagihara N; Walbridge S; Olson AW; Oldfield EH; Youle RJ
Cancer Res; 2000 Jan; 60(2):230-4. PubMed ID: 10667564
[TBL] [Abstract][Full Text] [Related]
15. Recombinant antibody fragments and immunotoxin fusions for cancer therapy.
Brinkmann U
In Vivo; 2000; 14(1):21-7. PubMed ID: 10757057
[TBL] [Abstract][Full Text] [Related]
16. Advances in anticancer immunotoxin therapy.
Alewine C; Hassan R; Pastan I
Oncologist; 2015 Feb; 20(2):176-85. PubMed ID: 25561510
[TBL] [Abstract][Full Text] [Related]
17. Clinical trials with intracerebral convection-enhanced delivery of targeted toxins in malignant glioma.
Rainov NG; Gorbatyuk K; Heidecke V
Rev Recent Clin Trials; 2008 Jan; 3(1):2-9. PubMed ID: 18474010
[TBL] [Abstract][Full Text] [Related]
18. [Recombinant immunotoxins and chimeric toxins for targeted therapy in oncology].
Chiron MF
Bull Cancer; 1997 Dec; 84(12):1135-40. PubMed ID: 9587366
[TBL] [Abstract][Full Text] [Related]
19. Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma.
Mintz A; Gibo DM; Madhankumar AB; Debinski W
J Neurooncol; 2003; 64(1-2):117-23. PubMed ID: 12952292
[TBL] [Abstract][Full Text] [Related]
20. Toxin conjugate therapy of cancer.
Wong L; Suh DY; Frankel AE
Semin Oncol; 2005 Dec; 32(6):591-5. PubMed ID: 16338425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
